Description

This workshop will examine the impact of mental health and treatment on lung function decline and risk of future exacerbations. In addition, the interpretations of conditional survival and reproducibility of FEV₁ will be described.

Learning Objectives:

• Describe the impact of depression, mucolytics, and antibiotics on lung function decline in the US and Europe.
• Identify a clinically meaningful change in FEV₁ for CF patients.
• Review the interpretation of conditional survival and the factors that are associated with an increased risk of death before age 30.

Workshop Chair(s):

• Jonathan Cogen, M.D., M.P.H., Assistant Professor

Speaker(s):

• David Nichols, M.D., Asst. Professor, National Jewish Health

Workshop Chair(s):

• Jenna Sykes, MMath, Research Biostatistician

Workshop Speaker(s):

• Edward McKone, M.D., Consultant Physician
• Michelle Murray, M.D., M.Sc., MRCPI, Doctor
• Michael Schechter, M.D., M.P.H., Director
• Sanja Stanojevic, Ph.D., Senior Research Associate